Toxicity and efficacy of re-irradiation of high-grade glioma in a phase I dose- and volume escalation trial.

CONCLUSION: Re-irradiation showed limited efficacy and 43% of patients achieving disease control suffered late toxicity that was manageable but not negligible.
PMID: 29054380 [PubMed - as supplied by publisher]

Source: Radiotherapy and Oncology : journal of the European Society for Therapeutic Radiology and Oncology - October 17, 2017 Category: Radiology Authors: Møller S, Munck Af Rosenschöld P, Costa J, Law I, Poulsen HS, Engelholm SA, Engelholm S Tags: Radiother Oncol Source Type: research